Monopar Therapeutics (MNPR) EPS (Basic) Growth (3y) (2020 - 2025)
Monopar Therapeutics (MNPR) EPS (Basic) Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 53.55% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.29% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.89% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.43% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Monopar Therapeutics | 707.36 Mn | 645.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 14.08% |
| Jun 30, 2025 | 31.12% |
| Mar 31, 2025 | 22.14% |
| Sep 30, 2024 | 24.58% |
| Jun 30, 2024 | 15.07% |
| Mar 31, 2024 | 11.92% |
| Sep 30, 2023 | 2.27% |
| Jun 30, 2023 | -8.37% |
| Mar 31, 2023 | -21.08% |
| Dec 31, 2022 | -37.39% |
| Sep 30, 2022 | -31.80% |
| Jun 30, 2022 | -30.29% |
| Mar 31, 2022 | -8.27% |
| Dec 31, 2021 | -43.59% |
| Sep 30, 2021 | -39.07% |
| Jun 30, 2021 | -31.34% |
| Mar 31, 2021 | -16.38% |
| Dec 31, 2020 | -51.10% |
| Sep 30, 2020 | 55.47% |
| Jun 30, 2020 | -25.81% |